Consilium Wealth Advisory LLC Acquires 464 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Consilium Wealth Advisory LLC lifted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 11.7% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 4,426 shares of the healthcare conglomerate’s stock after acquiring an additional 464 shares during the quarter. UnitedHealth Group makes up about 1.4% of Consilium Wealth Advisory LLC’s portfolio, making the stock its 20th biggest holding. Consilium Wealth Advisory LLC’s holdings in UnitedHealth Group were worth $2,588,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in UNH. Kathleen S. Wright Associates Inc. bought a new position in UnitedHealth Group during the 3rd quarter worth $27,000. Global Wealth Strategies & Associates lifted its stake in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after purchasing an additional 32 shares during the last quarter. Macroview Investment Management LLC raised its holdings in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 47 shares in the last quarter. West Financial Advisors LLC acquired a new position in UnitedHealth Group during the third quarter worth about $32,000. Finally, Delos Wealth Advisors LLC increased its position in UnitedHealth Group by 757.1% during the 1st quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 53 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

UNH has been the subject of a number of research reports. Hsbc Global Res cut UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 17th. Royal Bank of Canada cut their target price on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Bank of America decreased their price objective on UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. KeyCorp began coverage on UnitedHealth Group in a research note on Friday, October 11th. They issued an “overweight” rating and a $675.00 price target for the company. Finally, Argus upped their target price on UnitedHealth Group from $570.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $615.53.

UnitedHealth Group Stock Up 6.2 %

Shares of UNH stock traded up $35.19 during trading hours on Wednesday, reaching $602.22. The company had a trading volume of 2,262,627 shares, compared to its average volume of 3,878,905. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The company has a market cap of $556.10 billion, a price-to-earnings ratio of 36.94, a price-to-earnings-growth ratio of 1.64 and a beta of 0.58. The business has a fifty day simple moving average of $580.96 and a 200-day simple moving average of $543.36. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the firm earned $6.56 earnings per share. The business’s revenue was up 9.2% on a year-over-year basis. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.39%. UnitedHealth Group’s payout ratio is 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.